Rathbones Group Plc's Disclosure on Life Science REIT Holdings
In line with regulatory requirements, Rathbones Group Plc provides a comprehensive disclosure on their stake in Life Science REIT Plc. This disclosure is crucial for maintaining transparency in the market.
Key Information About the Disclosure
The disclosure outlines essential information whereby Rathbones Group Plc acknowledges its significant position in Life Science REIT Plc. This entails a detailed account of their ownership and trading activities concerning the company's securities.
Identity of Discloser
The full name of the entity making this disclosure is Rathbones Group Plc. As a major institutional investor, the group holds significant interests in various securities within the financial market.
Relevant Securities
In regards to interests in relevant securities, Rathbones Group Plc confirms ownership of a notable number of 1p Ordinary Shares in Life Science REIT Plc. The current holdings amount to approximately 49,879,809 shares. This represents about 14.25% of the total shares issued by Life Science REIT Plc.
Positions of Rathbones Group Plc in Life Science REIT Plc
Following recent dealings, Rathbones Group Plc's interests in Life Science REIT Plc remain a focal point for market observers. The company's stake showcases its commitment to the life sciences sector.
Details of Securities Held
As of the latest reporting date, Rathbones Group Plc has not disclosed any new positions or short interests beyond what is noted in public disclosures. The type of securities held includes only ordinary shares without any involvement in derivatives or other financial instruments related to Life Science REIT Plc.
Trading Activities and Transactions
Recent transactions by Rathbones Group Plc include various market dealings, highlighting their proactive management of investment positions. Notably, the firm executed multiple sales of shares within the reporting period.
Detailed Trading Information
Under the stipulated rules, Rathbones Group Plc has conducted sales of 12,600 shares at a price of 46.7515p and 41,000 shares at 46.66p, reflecting strategic decisions to manage their portfolio effectively. This trading activity emphasizes the responsiveness to market conditions and opportunities.
Future Commitments
No new options or derivative transactions have been registered, ensuring a clear and comprehensive understanding of their current and future commitments in relation to Life Science REIT Plc.
Regulatory Compliance and Contact Information
Rathbones Group Plc ensures all disclosures comply with regulatory standards set forth in the Takeover Code. This commitment is underscored by proactive engagement with stakeholder communications and adherence to public disclosure requirements.
Contact Details
For further inquiries, stakeholders are encouraged to reach out to Chinwe Enyi from the Compliance Department at Rathbones Group Plc. The contact number for inquiries is 0151 243 7053.
Frequently Asked Questions
What is the purpose of this disclosure?
The disclosure aims to provide transparency regarding Rathbones Group Plc's significant holdings and trading activities in Life Science REIT Plc.
How many shares does Rathbones Group Plc hold?
Rathbones Group Plc holds 49,879,809 shares, which is approximately 14.25% of the total issued shares of Life Science REIT Plc.
What types of transactions were reported?
The transactions included sales of ordinary shares at prevailing market prices.
Who can I contact for more information?
For inquiries, you may contact Chinwe Enyi of the Compliance Department at 0151 243 7053.
Is any other party being disclosed?
No, the disclosure is exclusive to Rathbones Group Plc's position in Life Science REIT Plc.
